MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Oct 2024 Evaluate
The quarter ended September 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 18.63 millions.The company has announced a 27.87% increase in its profits to Rs . 1.56  millions for the  quarter ended September 2024 compared to Rs. 1.22 millions in the corresponding quarter in the previous year.Operating profit surged to 2.52 millions from the corresponding previous quarter of 2.02 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 18.63 17.86 4.31 36.10 36.85 -2.04 70.30 71.55 -1.75
Other Income 0.78 0.76 2.63 1.45 1.20 20.83 2.75 1.72 59.88
PBIDT 2.52 2.02 24.75 4.78 3.97 20.40 8.17 7.81 4.61
Interest 0.12 0.09 33.33 0.21 0.17 23.53 0.37 0.52 -28.85
PBDT 2.40 1.93 24.35 4.57 3.80 20.26 7.80 7.29 7.00
Depreciation 0.32 0.33 -3.03 0.64 0.66 -3.03 1.30 1.29 0.78
PBT 2.08 1.60 30.00 3.93 3.14 25.16 6.50 6.00 8.33
TAX 0.52 0.38 36.84 1.00 0.70 42.86 1.64 1.42 15.49
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.12 -0.16 -25.00
PAT 1.56 1.22 27.87 2.93 2.44 20.08 4.86 4.58 6.11
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 13.53 11.31 19.60 13.24 10.77 22.90 11.62 10.92 6.47
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..